AVTR:NYE-Avantor Inc (USD)

COMMON STOCK | Medical Instruments & Supplies |

Last Closing

USD 24.73

Change

0.00 (0.00)%

Market Cap

USD 16.81B

Volume

4.38M

Analyst Target

USD 23.81
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, and compound management services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania. Address: Radnor Corporate Center, Radnor, PA, United States, 19087

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-20 )

Largest Industry Peers for Medical Instruments & Supplies

Symbol Name Price(Change) Market Cap
BDX Becton Dickinson and Company

N/A

USD 70.45B
ALC Alcon AG

N/A

USD 46.93B
RMD ResMed Inc

N/A

USD 35.22B
BAX Baxter International Inc

N/A

USD 18.81B
TFX Teleflex Incorporated

N/A

USD 11.31B
ATR AptarGroup Inc

N/A

USD 11.20B
BLCO Bausch + Lomb Corp

N/A

USD 7.26B
STVN Stevanato Group SpA

N/A

USD 4.99B
WRBY Warby Parker Inc

N/A

USD 1.86B
INFU InfuSystems Holdings Inc

N/A

USD 0.15B

ETFs Containing AVTR

COPP Sprott Copper Miners ETF 10.10 % 0.00 %

N/A

N/A
CEBS:XETRA iShares Copper Miners UCI.. 5.75 % 0.00 %

N/A

USD 0.05B
GMTL:AU Global X Green Metal Mine.. 4.94 % 0.00 %

N/A

N/A
XMET:AU BetaShares Energy Transit.. 4.93 % 0.00 %

N/A

N/A
COPX:SW Global X Copper Miners UC.. 4.56 % 0.00 %

N/A

N/A
D6AT:XETRA Global X Disruptive Mater.. 4.46 % 0.00 %

N/A

N/A
COPX:LSE Global X Copper Miners UC.. 4.31 % 0.00 %

N/A

N/A
DMAT Global X Disruptive Mater.. 3.85 % 0.00 %

N/A

USD 5.99M
M7ES:XETRA HANetf ICAV - Sprott Ener.. 3.68 % 0.00 %

N/A

USD 4.88M
SETM:LSE HANetf ICAV - Sprott Ener.. 3.38 % 0.00 %

N/A

USD 4.88M
MOED:XETRA BNP Paribas Easy - Equity.. 2.26 % 0.00 %

N/A

USD 2.20M
MOEU:XETRA BNP Paribas Easy ESG Equi.. 2.26 % 0.00 %

N/A

USD 2.20M
MOED:SW BNP Paribas Easy ESG Equi.. 2.26 % 0.00 %

N/A

USD 0.83M
CRIT Optica Rare Earths & Crit.. 2.25 % 0.00 %

N/A

USD 3.93M
MEM MAYBANK EMERGING ETF 1.97 % 0.00 %

N/A

USD 0.06B
ZMID:CA BMO S&P US Mid Cap Index .. 0.64 % 0.00 %

N/A

N/A
MDY SPDR® S&P MIDCAP 400 ETF.. 0.62 % 0.24 %

N/A

USD 23.63B
SPY4:XETRA SSgA SPDR S&P 400 US Mid .. 0.61 % 0.00 %

N/A

USD 1.99B
SPY4:SW SPDR® S&P 400 US Mid Cap.. 0.61 % 0.00 %

N/A

USD 2.71B
IVOO Vanguard S&P Mid-Cap 400 .. 0.60 % 0.15 %

N/A

USD 2.26B
BSJO Invesco BulletShares 2024.. 0.00 % 0.42 %

N/A

N/A
HYDW Xtrackers Low Beta High Y.. 0.00 % 0.25 %

N/A

USD 0.28B
PQIN 0.00 % 0.00 %

N/A

N/A
IESZ:LSE 0.00 % 0.00 %

N/A

N/A
EMOM:PA BNP Paribas Easy ESG Equi.. 0.00 % 0.00 %

N/A

USD 2.00M
MOED:PA BNP Paribas Easy - Equity.. 0.00 % 0.00 %

N/A

USD 0.82M
SPY4:PA SSgA SPDR S&P 400 US Mid .. 0.00 % 0.00 %

N/A

USD 2.60B
EXV6:F iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

N/A
EXV6:XETRA iShares STOXX Europe 600 .. 0.00 % 0.00 %

N/A

USD 0.37B
ZMID-F:CA BMO S&P US Mid Cap Index .. 0.00 % 0.00 %

N/A

CAD 2.03M
ZMID-U:CA BMO S&P US Mid Cap Index .. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Instruments & Supplies) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.32% 63% D 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.32% 63% D 55% F
Trailing 12 Months  
Capital Gain 20.40% 68% D+ 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.40% 68% D+ 55% F
Trailing 5 Years  
Capital Gain 77.66% 81% B- 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 77.66% 81% B- 79% B-
Average Annual (5 Year Horizon)  
Capital Gain 16.89% 79% B- 79% B-
Dividend Return 16.89% 79% B- 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 48.41% 42% F 19% F
Risk Adjusted Return 34.88% 84% B 52% F
Market Capitalization 16.81B 71% C- 90% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector